| A reference human induced pluripotent stem cell line for large-scale collaborative studies CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendraat, L Peng, ... Cell stem cell 29 (12), 1685-1702. e22, 2022 | 103 | 2022 |
| The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ... Movement Disorders 34 (4), 460-468, 2019 | 85 | 2019 |
| Multi-modality machine learning predicting Parkinson’s disease MB Makarious, HL Leonard, D Vitale, H Iwaki, L Sargent, A Dadu, I Violich, ... npj Parkinson's Disease 8 (1), 35, 2022 | 80 | 2022 |
| Accelerating medicines partnership: Parkinson's disease. Genetic resource H Iwaki, HL Leonard, MB Makarious, M Bookman, B Landin, D Vismer, ... Movement Disorders 36 (8), 1795-1804, 2021 | 80 | 2021 |
| Underrepresented populations in Parkinson's genetics research: current landscape and future directions AF Schumacher‐Schuh, A Bieger, O Okunoye, KY Mok, SY Lim, ... Movement Disorders 37 (8), 1593-1604, 2022 | 45 | 2022 |
| Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease JJ Kim, D Vitale, DV Otani, MM Lian, K Heilbron, H Iwaki, J Lake, ... Nature genetics 56 (1), 27-36, 2024 | 44 | 2024 |
| Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study M Rizig, S Bandres-Ciga, MB Makarious, OO Ojo, PW Crea, OV Abiodun, ... The Lancet Neurology 22 (11), 1015-1025, 2023 | 43 | 2023 |
| Multi-ancestry meta-analysis and fine-mapping in Alzheimer’s disease J Lake, C Warly Solsberg, JJ Kim, J Acosta-Uribe, MB Makarious, Z Li, ... Molecular Psychiatry 28 (7), 3121-3132, 2023 | 35 | 2023 |
| funtrp: identifying protein positions for variation driven functional tuning M Miller, D Vitale, PC Kahn, B Rost, Y Bromberg Nucleic acids research 47 (21), e142-e142, 2019 | 29 | 2019 |
| Evidence for GRN connecting multiple neurodegenerative diseases MA Nalls, C Blauwendraat, L Sargent, D Vitale, H Leonard, H Iwaki, ... Brain Communications 3 (2), fcab095, 2021 | 28 | 2021 |
| Genome‐wide analysis of structural variants in Parkinson disease KJ Billingsley, J Ding, PA Jerez, A Illarionova, K Levine, FP Grenn, ... Annals of neurology 93 (5), 1012-1022, 2023 | 19 | 2023 |
| Genetic risk factor clustering within and across neurodegenerative diseases MJ Koretsky, C Alvarado, MB Makarious, D Vitale, K Levine, ... Brain 146 (11), 4486-4494, 2023 | 18 | 2023 |
| Large-scale rare variant burden testing in Parkinson's disease MB Makarious, J Lake, V Pitz, A Ye Fu, JL Guidubaldi, CW Solsberg, ... Brain 146 (11), 4622-4632, 2023 | 17 | 2023 |
| GenoML: automated machine learning for genomics MB Makarious, HL Leonard, D Vitale, H Iwaki, D Saffo, L Sargent, A Dadu, ... arXiv preprint arXiv:2103.03221, 2021 | 15 | 2021 |
| Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2) C Towns, M Richer, S Jasaityte, EJ Stafford, J Joubert, T Antar, ... npj Parkinson's Disease 9 (1), 131, 2023 | 10 | 2023 |
| Genome-wide association identifies novel etiological insights associated with Parkinson’s disease in African and African Admixed Populations M Rizig, S Bandres-Ciga, MB Makarious, O Ojo, PW Crea, O Abiodun, ... medRxiv, 2023 | 10 | 2023 |
| Neurobooster array: a genome-wide genotyping platform to study neurological disorders across diverse populations S Bandres-Ciga, F Faghri, E Majounie, MJ Koretsky, J Kim, KS Levine, ... medRxiv, 2023 | 9 | 2023 |
| Polygenic Parkinson's disease genetic risk score as risk modifier of parkinsonism in Gaucher disease C Blauwendraat, N Tayebi, EG Woo, G Lopez, L Fierro, M Toffoli, ... Movement Disorders 38 (5), 899-903, 2023 | 9 | 2023 |
| GenoTools: An open-source Python package for efficient genotype data quality control and analysis D Vitale, M Koretsky, N Kuznetsov, S Hong, J Martin, M James, ... bioRxiv, 2024.03. 26.586362, 2024 | 4 | 2024 |
| omicSynth: an open multi‐omic community resource for identifying druggable targets across neurodegenerative diseases CX Alvarado, MB Makarious, D Vitale, MJ Koretsky, S Bandres‐Ciga, ... Alzheimer's & Dementia 19, e082359, 2023 | 4 | 2023 |
